Cellply

Private

BolognaHealthcare & Life Scienceshttps://www.cellply.com/

Last Round

Early Funding

May 11, 2026

Total Funding Raised

$12.47M

Company Overview

Cellply is a biotechnology company that develops analytical tools enabling the development of life-saving cancer cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Precision Medicine, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

single-cell analysiscell potency assaycell therapy developmentimmunotherapy developmentmicrofluidicscell analysis platformAI-powered image analysislab-on-a-chipCAR-T therapycell therapy QCmicrofluidic chipslife science instrumentslab automationbiotech equipmentcell characterization servicerazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellply Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cellply Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	May 11, 2026
Series A Extension	Sep 27, 2023
Seed	Dec 14, 2021
Grant	Aug 2, 2018
Pre Seed	Mar 20, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Massimo Bocchi

Founder Chief Operating Officer

Founding Team

Cellply Investors

Notable investors and investment history

Investor	Rounds
Meta Ventures	Seed
European Commission	Grant
Indaco Venture Partners SGR	Seed
Rearden	Seed
CDP Venture Capital SGR	Early Funding
LIFTT EuroInvest	Seed, Series A Extension
ENEA-Tech and Biomedical Foundation	Early Funding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 11, 2026
$8.4M raised with ENEA-Tech and CDP Venture Capital.

View all signals

Cellply Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cellply Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellply's valuation, stock price, and market status.

Firmographic Details

HeadquartersBologna

Employee Range27

Year Founded2013

Last FundingMay 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.